AZITHROMYCIN IN THE TREATMENT OF MONOCYTIC EHRLICHIOSIS IN NATURALLY INFECTED DOGS
DOI:
https://doi.org/10.1590/cab.v15i4.5553Keywords:
Animal SanityAbstract
The aims of this study were to evaluate the effectiveness of treatment with azithromycin in dogs naturally infected with E. canis, and to analyse the clinical and hematological changes the animals would show. Ten dogs with positive diagnosis for E. canis through Elisa Snap 4Dx test were distributed into two groups, untreated and treated with azithromycin, 20 mg/kg, orally once a day for seven days. In addition to the physical exam, complete blood counts (CBC), smears made out from blood of the ear margin in order to detect ehrlichial morulae and nested PCR before treatment and post-treatment were performed. We found that the treatment was not effective, since the clinical signs did not disappear, as well as there was no return to normal values of the CBC in treated animas, neither the elimination of E. canis from the infected animals.
Keywords: azithromycin; Ehrlichia canis; PCR; Dogs.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
